Net profit of Senores Pharmaceuticals rose 84.28% to Rs 31.66 crore in the quarter ended December 2025 as against Rs 17.18 crore during the previous quarter ended December 2024. Sales rose 60.02% to Rs 164.85 crore in the quarter ended December 2025 as against Rs 103.02 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales164.85103.02 60 OPM %32.7624.94 - PBDT52.4624.69 112 PBT44.6020.49 118 NP31.6617.18 84 Powered by Capital Market - Live News

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 January 2026.Powered by Capital Market - Live News

Senores Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2026.Powered by Capital Market - Live News

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 January 2026.Powered by Capital Market - Live News

Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales153.3698.26 56 OPM %32.2823.68 - PBDT48.7319.86 145 PBT40.6415.97 154 NP32.3812.84 152 Powered by Capital Market - Live News